ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 133 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $84,728,000 | +74.8% | 4,492,466 | +9.1% | 1.58% | +90.3% |
Q2 2019 | $48,478,000 | +176.0% | 4,118,806 | +220.1% | 0.83% | -14.3% |
Q1 2019 | $17,564,000 | +52.5% | 1,286,748 | +14.5% | 0.97% | +27.6% |
Q4 2018 | $11,519,000 | -23.6% | 1,123,813 | +24.1% | 0.76% | -20.8% |
Q3 2018 | $15,072,000 | +25.7% | 905,254 | +19.3% | 0.96% | -6.5% |
Q2 2018 | $11,992,000 | +34.8% | 758,964 | +8.4% | 1.02% | +16.0% |
Q1 2018 | $8,896,000 | +2441.7% | 700,464 | +2189.1% | 0.88% | +2281.1% |
Q4 2017 | $350,000 | -13.4% | 30,600 | -7.3% | 0.04% | -11.9% |
Q3 2017 | $404,000 | +6.9% | 33,000 | 0.0% | 0.04% | -6.7% |
Q2 2017 | $378,000 | -44.9% | 33,000 | 0.0% | 0.04% | -50.5% |
Q1 2017 | $686,000 | 0.0% | 33,000 | 0.0% | 0.09% | -35.0% |
Q4 2016 | $686,000 | -36.5% | 33,000 | 0.0% | 0.14% | -28.2% |
Q3 2016 | $1,081,000 | +31.2% | 33,000 | 0.0% | 0.20% | +25.8% |
Q2 2016 | $824,000 | +2.0% | 33,000 | 0.0% | 0.16% | +5.4% |
Q1 2016 | $808,000 | – | 33,000 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 1,628,328 | $33,869,000 | 14.72% |
Foresite Capital Management II, LLC | 995,396 | $20,704,000 | 10.39% |
Cormorant Asset Management, LP | 1,581,604 | $32,897,000 | 4.43% |
DAFNA Capital Management LLC | 221,013 | $4,597,000 | 4.04% |
New Leaf Venture Partners, L.L.C. | 228,428 | $4,751,000 | 3.40% |
Partner Investment Management, L.P. | 63,571 | $1,322,000 | 1.75% |
Iguana Healthcare Management, LLC | 140,000 | $2,912,000 | 1.74% |
PFM Health Sciences, LP | 2,913,951 | $60,610,000 | 1.71% |
Redmile Group, LLC | 920,550 | $19,147,000 | 1.65% |
SECTORAL ASSET MANAGEMENT INC | 669,351 | $13,923,000 | 1.54% |